258 related articles for article (PubMed ID: 29526828)
1. Controlled release of an HDAC inhibitor for reduction of inflammation in dry eye disease.
Ratay ML; Balmert SC; Bassin EJ; Little SR
Acta Biomater; 2018 Apr; 71():261-270. PubMed ID: 29526828
[TBL] [Abstract][Full Text] [Related]
2. Treg-recruiting microspheres prevent inflammation in a murine model of dry eye disease.
Ratay ML; Glowacki AJ; Balmert SC; Acharya AP; Polat J; Andrews LP; Fedorchak MV; Schuman JS; Vignali DAA; Little SR
J Control Release; 2017 Jul; 258():208-217. PubMed ID: 28501670
[TBL] [Abstract][Full Text] [Related]
3. TRI Microspheres prevent key signs of dry eye disease in a murine, inflammatory model.
Ratay ML; Balmert SC; Acharya AP; Greene AC; Meyyappan T; Little SR
Sci Rep; 2017 Dec; 7(1):17527. PubMed ID: 29235530
[TBL] [Abstract][Full Text] [Related]
4. Histone deacetylase inhibitors SAHA and sodium butyrate block G1-to-S cell cycle progression in neurosphere formation by adult subventricular cells.
Zhou Q; Dalgard CL; Wynder C; Doughty ML
BMC Neurosci; 2011 May; 12():50. PubMed ID: 21615950
[TBL] [Abstract][Full Text] [Related]
5. SAHA, an HDAC inhibitor, synergizes with tacrolimus to prevent murine cardiac allograft rejection.
Zhang X; Han S; Kang Y; Guo M; Hong S; Liu F; Fu S; Wang L; Wang QX
Cell Mol Immunol; 2012 Sep; 9(5):390-8. PubMed ID: 22922441
[TBL] [Abstract][Full Text] [Related]
6. Effects of histone deacetylase inhibitor SAHA on effector and FOXP3+regulatory T cells in rhesus macaques.
Johnson J; Pahuja A; Graham M; Hering B; Hancock WW; Bansal-Pakala P
Transplant Proc; 2008 Mar; 40(2):459-61. PubMed ID: 18374101
[TBL] [Abstract][Full Text] [Related]
7. Assessment of new HDAC inhibitors for immunotherapy of malignant pleural mesothelioma.
Bensaid D; Blondy T; Deshayes S; Dehame V; Bertrand P; Grégoire M; Errami M; Blanquart C
Clin Epigenetics; 2018; 10():79. PubMed ID: 29946373
[TBL] [Abstract][Full Text] [Related]
8. Pigment Epithelium-Derived Factor Enhances the Suppressive Phenotype of Regulatory T Cells in a Murine Model of Dry Eye Disease.
Singh RB; Blanco T; Mittal SK; Alemi H; Chauhan SK; Chen Y; Dana R
Am J Pathol; 2021 Apr; 191(4):720-729. PubMed ID: 33453179
[TBL] [Abstract][Full Text] [Related]
9. The Immunological Basis of Dry Eye Disease and Current Topical Treatment Options.
Periman LM; Perez VL; Saban DR; Lin MC; Neri P
J Ocul Pharmacol Ther; 2020 Apr; 36(3):137-146. PubMed ID: 32175799
[TBL] [Abstract][Full Text] [Related]
10. ICAM-1 expression predisposes ocular tissues to immune-based inflammation in dry eye patients and Sjögrens syndrome-like MRL/lpr mice.
Gao J; Morgan G; Tieu D; Schwalb TA; Luo JY; Wheeler LA; Stern ME
Exp Eye Res; 2004 Apr; 78(4):823-35. PubMed ID: 15037117
[TBL] [Abstract][Full Text] [Related]
11. Effects of novel HDAC inhibitors on urothelial carcinoma cells.
Kaletsch A; Pinkerneil M; Hoffmann MJ; Jaguva Vasudevan AA; Wang C; Hansen FK; Wiek C; Hanenberg H; Gertzen C; Gohlke H; Kassack MU; Kurz T; Schulz WA; Niegisch G
Clin Epigenetics; 2018 Jul; 10(1):100. PubMed ID: 30064501
[TBL] [Abstract][Full Text] [Related]
12. Improving allogeneic islet transplantation by suppressing Th17 and enhancing Treg with histone deacetylase inhibitors.
Sugimoto K; Itoh T; Takita M; Shimoda M; Chujo D; SoRelle JA; Naziruddin B; Levy MF; Shimada M; Matsumoto S
Transpl Int; 2014 Apr; 27(4):408-15. PubMed ID: 24410777
[TBL] [Abstract][Full Text] [Related]
13. Histone deacetylase inhibition regulates inflammation and enhances Tregs after allogeneic hematopoietic cell transplantation in humans.
Choi SW; Gatza E; Hou G; Sun Y; Whitfield J; Song Y; Oravecz-Wilson K; Tawara I; Dinarello CA; Reddy P
Blood; 2015 Jan; 125(5):815-9. PubMed ID: 25428224
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of multiple pathogenic pathways by histone deacetylase inhibitor SAHA in a corneal alkali-burn injury model.
Li X; Zhou Q; Hanus J; Anderson C; Zhang H; Dellinger M; Brekken R; Wang S
Mol Pharm; 2013 Jan; 10(1):307-18. PubMed ID: 23186311
[TBL] [Abstract][Full Text] [Related]
15. Histone/protein deacetylase inhibitors increase suppressive functions of human FOXP3+ Tregs.
Akimova T; Ge G; Golovina T; Mikheeva T; Wang L; Riley JL; Hancock WW
Clin Immunol; 2010 Sep; 136(3):348-63. PubMed ID: 20478744
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological characterization of histone deacetylase inhibitor and tumor cell-growth inhibition properties of new benzofuranone compounds.
Blanquart C; François M; Charrier C; Bertrand P; Gregoire M
Curr Cancer Drug Targets; 2011 Oct; 11(8):919-28. PubMed ID: 21762083
[TBL] [Abstract][Full Text] [Related]
17. Proteoglycan 4 (PRG4) expression and function in dry eye associated inflammation.
Menon NG; Goyal R; Lema C; Woods PS; Tanguay AP; Morin AA; Das N; Jay GD; Krawetz RJ; Dufour A; Shapiro LH; Redfern RL; Ghosh M; Schmidt TA
Exp Eye Res; 2021 Jul; 208():108628. PubMed ID: 34048779
[TBL] [Abstract][Full Text] [Related]
18. Boosting regulatory T cells limits neuroinflammation in permanent cortical stroke.
Liesz A; Zhou W; Na SY; Hämmerling GJ; Garbi N; Karcher S; Mracsko E; Backs J; Rivest S; Veltkamp R
J Neurosci; 2013 Oct; 33(44):17350-62. PubMed ID: 24174668
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of Histone Deacetylase Activity Aggravates Coxsackievirus B3-Induced Myocarditis by Promoting Viral Replication and Myocardial Apoptosis.
Zhou L; He X; Gao B; Xiong S
J Virol; 2015 Oct; 89(20):10512-23. PubMed ID: 26269170
[TBL] [Abstract][Full Text] [Related]
20. Pendant HDAC inhibitor SAHA derivatised polymer as a novel prodrug micellar carrier for anticancer drugs.
Xu J; Sun J; Wang P; Ma X; Li S
J Drug Target; 2018; 26(5-6):448-457. PubMed ID: 29251528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
